Cite
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.
MLA
Melvin, Jennifer C., et al. “Glucose and Lipoprotein Biomarkers and Breast Cancer Severity Using Data from the Swedish AMORIS Cohort.” BMC Cancer, vol. 17, Apr. 2017, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12885-017-3232-6.
APA
Melvin, J. C., Garmo, H., Holmberg, L., Hammar, N., Walldius, G., Jungner, I., Lambe, M., & Van Hemelrijck, M. (2017). Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort. BMC Cancer, 17, 1–11. https://doi.org/10.1186/s12885-017-3232-6
Chicago
Melvin, Jennifer C., Hans Garmo, Lars Holmberg, Niklas Hammar, Göran Walldius, Ingmar Jungner, Mats Lambe, and Mieke Van Hemelrijck. 2017. “Glucose and Lipoprotein Biomarkers and Breast Cancer Severity Using Data from the Swedish AMORIS Cohort.” BMC Cancer 17 (April): 1–11. doi:10.1186/s12885-017-3232-6.